ClinicalTrials.govpublic full text
Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma
recurrent b-cell non-hodgkin lymphoma, recurrent diffuse large b-cell lymphoma, recurrent hodgkin lymphoma, refractory b-cell non-hodgkin lymphoma, refractory diffuse large b-cell lymphoma, refractory hodgkin lymphoma
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 454010
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.